Company Search:
Advanced Search
Sponsored Links
Grifols SA Company Snapshot
Grifols SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grifols SA with three other pharmaceutical manufacturers in Europe: UCB Sa of Belgium (2018 sales of 4.63 billion Euro [US$5.11 billion] of which 31% was Cimzia), Ipsen SA of France (2.35 billion Euro [US$2.59 billion] of which 82% was Specialty Care), and Qiagen N.V. which is based in the Netherlands (1.27 billion Euro [US$1.41 billion] of which 88% was Consumables and Related Revenues).

Sales Analysis. Grifols SA reported sales of 4.49 billion Euro (US$4.95 billion) for the year ending December of 2018. This represents an increase of 3.9% versus 2017, when the company's sales were 4.32 billion Euro. Sales at Grifols SA have increased during each of the previous five years (and since 2013, sales have increased a total of 64%). Sales of Bio Supplies saw an increase that was more than double the company's growth rate: sales were up 150.0% in 2018, from 66.79 million Euro to 167.00 million Euro. Grifols SA also saw significant increases in sales in Hospital (up 19.3% to 119.45 million Euro) and Others/raw Materials (up 22.9% to 22.45 million Euro) . Not all segments of Grifols SA experienced an increase in sales in 2018: sales of Diagnostics fell 0.1% to 702.27 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grifols SA
  Stock Performance Chart for Grifols SA
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 31.16
(Figures in Euro)
1 Week -2.0%   13 Weeks -2.9%  
4 Weeks 12.1%   52 Weeks 31.0%  
Grifols SA Key Data:
  Ticker: GRF Country: Spain
  Exchanges: MAD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 4,486,724,000
(Year Ending Jan 2019).
Employees: 21,243
  Currency: Euro Market Cap: 21,317,657,350
  Fiscal Yr Ends: December Shares Outstanding: 684,135,345
  Share Type: ORDINARY Closely Held Shares: 145,690,603
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.